← Back
Data updated: Mar 10, 2026
OVERSEAS
Respiratory
OVERSEAS is a generic drug manufacturer focused on Respiratory.
2020
Since
1
Drugs
-
Trials
114
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LEVETIRACETAM 2025-12-02
LEVETIRACETAM 2025-11-21
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-06
Labeling
LEVETIRACETAM 2025-07-09
Labeling
LEVETIRACETAM 2025-04-04
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 100%
0 drugs Phase 1: 3
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-06-11
- Latest
- 2022-07-20
- Applications
- 1